Advertisement
Canada markets close in 3 hours 30 minutes
  • S&P/TSX

    21,767.71
    +59.27 (+0.27%)
     
  • S&P 500

    4,967.99
    -43.13 (-0.86%)
     
  • DOW

    37,851.48
    +76.10 (+0.20%)
     
  • CAD/USD

    0.7267
    +0.0003 (+0.05%)
     
  • CRUDE OIL

    82.97
    +0.24 (+0.29%)
     
  • Bitcoin CAD

    87,628.52
    -236.77 (-0.27%)
     
  • CMC Crypto 200

    1,378.82
    +66.20 (+5.04%)
     
  • GOLD FUTURES

    2,405.60
    +7.60 (+0.32%)
     
  • RUSSELL 2000

    1,941.28
    -1.68 (-0.09%)
     
  • 10-Yr Bond

    4.6100
    -0.0370 (-0.80%)
     
  • NASDAQ

    15,315.57
    -285.93 (-1.83%)
     
  • VOLATILITY

    18.93
    +0.93 (+5.18%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • CAD/EUR

    0.6827
    +0.0006 (+0.09%)
     

Stocks in play: Microbix Biosystems Inc.

Will present performance results of its Quality Assessment Products supporting molecular-diagnostic tests for the Omicron variant of the SARS-CoV-2 virus at the 2022 Clinical Virology Symposium of the American Society for Microbiology taking place in West Palm Beach, Florida from May 1-4. Microbix Biosystems Inc. shares T.MBX are trading unchanged at $0.52.

Read: